Tim Akhurst

[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

Michael S. Hofman, John Violet, Rodney J. Hicks et al. · The Lancet Oncology · 2018 · 1.1K citations

Dosimetry of ¹⁷⁷Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes

John Violet, Price Jackson, Justin Ferdinandus et al. · Journal of Nuclear Medicine · 2018 · 454 citations · Full text

Lessons Learned From 500 Cases of Lymphatic Mapping for Breast Cancer

Arnold Hill, Katherine N. Tran, Tim Akhurst et al. · Annals of Surgery · 1999 · 363 citations

Whole Body ¹⁸FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial

Robert J. Downey, Tim Akhurst, David H. Ilson et al. · Journal of Clinical Oncology · 2003 · 320 citations

Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology

Thomas Beyer, Gerald Antoch, Todd M. Blodgett et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 298 citations

Computed Tomography, Engineering, Respiratory Motion +14